FDA Inspection 1178579 — Heartland Center for Reproductive Medicine, PC

Heartland Center for Reproductive Medicine, PC — FEI 3004562631

The FDA completed an inspection of Heartland Center for Reproductive Medicine, PC on July 29, 2022 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 29, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Omaha, NE (United States)